ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $353,782 | -95.5% | 12,370 | -89.7% | 0.00% | -99.1% |
| Q4 2021 | $7,927,000 | +6.2% | 119,565 | +0.0% | 0.11% | -4.2% |
| Q3 2021 | $7,464,000 | -14.9% | 119,562 | +12.9% | 0.12% | -15.6% |
| Q2 2021 | $8,772,000 | +16.3% | 105,920 | -6.9% | 0.14% | -4.7% |
| Q1 2021 | $7,545,000 | -14.6% | 113,788 | -1.1% | 0.15% | -15.4% |
| Q4 2020 | $8,831,000 | +1006.6% | 115,090 | +521.2% | 0.18% | +169.2% |
| Q3 2020 | $798,000 | +14.5% | 18,526 | +14.8% | 0.06% | 0.0% |
| Q2 2020 | $697,000 | – | 16,135 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |